Corpus Intelligence IC Memo — OKLAHOMA HEART HOSPITAL SOUTH 2026-04-26 05:23 UTC
IC Memo — OKLAHOMA HEART HOSPITAL SOUTH
Investment Committee Memorandum | OK | 43 beds | Grade C | EBITDA uplift $10.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OKLAHOMA HEART HOSPITAL SOUTH

CCN 370234 | OKLAHOMA, OK | 43 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OKLAHOMA HEART HOSPITAL SOUTH is a 43-bed suburban community hospital in OKLAHOMA, OK with $148.5M in net patient revenue and a -0.6% operating margin. The hospital serves a payer mix of 37.0% Medicare, 10.8% Medicaid, and 52.2% commercial.

Thesis: Turnaround. Our ML models identify $10.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.6% to 6.8% (+736bps).

Net Revenue HCRIS$148.5M
Current EBITDA COMPUTED$-854K
Operating Margin COMPUTED-0.6%
Occupancy HCRIS89.8%
Revenue / Bed COMPUTED$3.5M
Net-to-Gross HCRIS23.9%
Distress Probability ML37.1%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
92
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -0.6% places it above the state median. Among 92 size-comparable peers (22-86 beds), the median margin is -9.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-86), prioritizing same-state peers. 92 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OKLAHOMA HEART HOSPITAL SOUTH (Target)OK43$148.5M-0.6%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
OKLAHOMA SURGICAL HOSPITALOK74$146.2M17.7%
COMMUNITY HOSPITALOK45$143.9M21.7%
NORTHEASTERN HEALTH SYSTEMOK80$134.6M-9.6%
INTEGRIS HEALTH EDMONDOK77$119.4M-3.8%
JANE PHILLIPS MEDICAL CENTEROK81$117.9M-9.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$3.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$95K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$3.0M
Denial Rate Reduction
$2.9M
A/R Days Reduction
$1.8M
Clean Claim Rate
$95K
Total EBITDA Uplift$10.9M
Current EBITDA$-854K
+ RCM Uplift+$10.9M
Pro Forma EBITDA$10.1M
Current Margin-0.6%
Pro Forma Margin6.8%
WC Released (1x)$5.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.3M$103.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.3M$113.6M0.00x-100.0%
Bull Case9.0x11.0x$-1.2M$149.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.2M$162.5M0.00x-100.0%
Bear Case11.0x10.0x$-1.4M$49.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.4M$53.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 92 hospitals with 22-86 beds
  • Same-state prioritization (n=93)
  • Comp margins: P25=-23.3% / P50=-9.7% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.